SCHEMBL7226462

SCHEMBL7226462

CCNC(=O)[C@@]1(n2cnc3c(N)ncnc32)O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 8/20 0.51
▸ HSP90B1 P14625 2/20 0.51
▸ ADORA2A P29274 5/20 0.48
▸ TSHR P16473 3/20 0.48
▸ MAPK1 P28482 3/20 0.48
▸ ADORA2B P29275 3/20 0.48
▸ ADORA1 P30542 2/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ HSP90AA1 P07900 1/20 0.48
▸ TMIGD3 P0DMS9 1/20 0.48
▸ RXFP1 Q9HBX9 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ PI4KA P42356 2/20 0.46
▸ PI4K2B Q8TCG2 2/20 0.46
▸ PI4K2A Q9BTU6 2/20 0.46
▸ PI4KB Q9UBF8 2/20 0.46
▸ DPP4 P27487 1/20 0.45
▸ SLC28A1 O00337 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219553 0.87 ADORA3 (0.49) ADORA3ADORA2AMAPK1ADORA2BADORA1
SCHEMBL2463541 0.86 ADORA3 (0.50) ADORA3HSP90B1ADORA2AMAPK1ADORA2B
SCHEMBL29655156 0.86 ADORA3 (0.50) ADORA3ADORA2AMAPK1ADORA2BADORA1
SCHEMBL15798672 0.85 ADORA3 (0.45) ADORA3ADORA2AMAPK1ADORA2BADORA1
SCHEMBL28824008 0.85 ADORA2A (0.43) ADORA3ADORA2AMAPK1ADORA2BADORA1
SCHEMBL6536153 0.85 PI4KA (0.46) ADORA3HSP90B1ADORA2AMAPK1ADORA2B
SCHEMBL11576067 0.84 HSP90B1 (0.48) ADORA3HSP90B1ADORA2AMAPK1ADORA2B
SCHEMBL2761283 0.84 PI4KA (0.47) ADORA3ADORA2AMAPK1ADORA2BADORA1
SCHEMBL18011010 0.84 SETD2 (0.44) ADORA3ADORA2AMAPK1ADORA2BADORA1
SCHEMBL18011012 0.84 SETD2 (0.44) ADORA3ADORA2AMAPK1ADORA2BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545002-B1 Treating asthma, diarrhea, insulin resistance, diabetes, ischemia/reprefusion injuries, diabetic retinopathy or hyperbaric oxygen-induced retinopathy UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2003-04-08 — — US disclosed
US-6376521-B1 ANTIINFLAMMATORY AGENTS; ANTIISCHEMIC AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2002-04-23 — — US disclosed
Send feedback